Liu, Elisa K.
Sulman, Erik P.
Wen, Patrick Y.
Kurz, Sylvia C.
Article History
First Online: 22 May 2020
Compliance with Ethics Guidelines
:
: E. Liu has nothing to disclose.Dr. Sulman reports grants and personal fees from AbbVie, grants, personal fees and non-financial support from Novocure, personal fees and non-financial support from Merck, personal fees and non-financial support from BrainLab, personal fees and non-financial support from Blue Earth Diagnositics, personal fees and non-financial support from Physician’s Education Resource, personal fees and non-financial support from Zai Lab, outside the submitted work.Dr. Wen reports grants from Agios, grants from Astra Zenenca, grants from Karyopharm, grants from Sanofi-Aventis, grants from Vascular Biogenics, other from Vascular Biogenics, other from Merck, grants from Celgene, grants from Eli Lily, grants from Kazia, grants from MediciNova, grants from Novartis, grants from Oncoceutics, grants from VBI Vaccines, personal fees from Astra Zeneca, personal fees from Bayer, personal fees from Blue Earth Diagnostics, personal fees from Karyopharm, personal fees from Tocagen, personal fees from Integral Health, personal fees from Prime Oncology, personal fees from Imvax, personal fees from Elevate Bio, and personal fees from QED, outside the submitted work.Dr. Kurz reports that she is the principal investigator on two immunotherapy studies that have been mentioned in this work (NCT02968940, NCT03367715).
: This article does not contain any studies with human or animal subjects performed by any of the authors.